#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Transitional cell cancer of the renal pelvis and ureter PIK3CA-activated mutation Adult T-cell lymphoma/leukaemia refractory Cutaneous T-cell lymphoma T-cell type acute leukaemia Pseudomyxoma peritonei Philadelphia positive chronic myeloid leukaemia Small intestine adenocarcinoma Hereditary angioedema with C1 esterase inhibitor deficiency Congenital pseudarthrosis Autoimmune hepatitis Enteritis Still's disease Malignant peritoneal neoplasm Pancreatic carcinoma More trials…

    Learn about Rare Diseases

    Prolymphocytic leukaemia – Basic Information Glomerulonephritis membranoproliferative – Diagnostics Leiomyosarcoma – Trials in Disease Mantle cell lymphoma – Treatment Proteus syndrome Pulmonary sarcoidosis – Diagnostics Mantle cell lymphoma Paraneoplastic neurological syndrome – Trials in Disease Pulmonary fibrosis – Trials in Disease Chronic granulomatous disease – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tofacitinib L-Lysine Hydrochloride Macrogol 4000 Caplacizumab Tilsotolimod Sodium Escitalopram Oxalate Avatrombopag Elezanumab Apitegromab Fremanezumab Mk-1088 Benserazide Hydrochloride APROTININ Rosuvastatin Sulfasalazine Amlodipine Linvoseltamab Nafarelin Ketamine Difelikefalin More therapies…

    Learn about Your Condition

    Hyperchylomicronaemia Non-Hodgkin's lymphoma Osteosarcoma recurrent Adrenal insufficiency Hereditary angioedema Procedural pain Phaeochromocytoma Large cell lung cancer stage 0 Autoimmune hepatitis Erythema migrans Cerebrovascular accident Hyperkalaemia Netherton's syndrome Anal cancer stage II Atrial flutter More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hôpital Guy de Chauliac

Hôpital Guy de Chauliac

80 avenue Augustin Fliche, 34295 Montpellier cedex 5, Montpellier, 34295, France

Want to learn more about this study or check if you can participate? Contact us.

  • Efficacy, Safety, and Immunogenicity of mRNA-1647 Vaccine in Preventing Primary Cytomegalovirus Infection in CMV-Seronegative Females Aged 16-40

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Sodium Chloride
    Belgium Estonia Finland France Germany Italy +1
  • Study on the Effects and Safety of JR-141 and Idursulfase for Patients with Hunter Syndrome

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Mucopolysaccharidosis II
    Investigated Drugs:
    • Idursulfase
    • Pabinafusp Alfa
    France Germany Italy Poland Spain

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!